Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma
Aim. To assess the prognostic value of clinical and hematological parameters used by hematologists for risk stratification in diffuse large B-cell lymphoma (DLBCL), and to justify the need for discovering new prognostic factors. Methods. The trial included 101 patients (48 men and 53 women) with...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Russo |
| Foilsithe / Cruthaithe: |
Practical Medicine Publishing House
2019-01-01
|
| Sraith: | Клиническая онкогематология |
| Ábhair: | |
| Rochtain ar líne: | https://bloodjournal.ru/index.php/coh/article/view/296 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|